Oxbridge Biotech Roundtable has teamed up with SR One ‘ the venture capital arm of GlaxoSmithKline, to bring the world’s largest biotech business plan competition to North America. Welcome to OneStart.
We are looking for innovative ideas from across healt”d the life sciences which have the potential to deliver meaningful impact on the lives of patients. We welcome ideas at all stages of development from any of 4 traccf t
Send this to a friend